Health Care • Medical/Nursing Services
$0.27 ▼ -0.01
(-2.43%)
MKT CAP: $27.0M • VOL: 681.4K
52W L $0 52W H $1
DCGO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $322.2M | $616.6M | $624.3M |
| YoY Revenue Growth % | -47.7% | -1.2% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$178.0M | $28.7M | $15.1M |
| Operating Margin % | -55.3% | 4.7% | 2.4% |
| Net Income (GAAP) | -$196.4M | $13.4M | $10.0M |
| EBITDA (Normalized) | -$174.4M | $31.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $34.5M | $70.1M | -$64.5M |
| Capital Expenditures (CapEx) | $4.5M | $3.6M | — |
| Free Cash Flow (FCF) | $29.9M | $66.5M | -$64.5M |
| FCF Margin % | 9.3% | 10.8% | -10.3% |
| Return on Invested Capital (ROIC %) | -45.0% | 9.8% | — |
| Cash & Short-Term Equivalents | $51.0M | $89.2M | — |
| Total Debt (Short + Long Term) | $183.8K | $5.2K | — |
| Total Stockholders' Equity | $144.0M | $320.9M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR DCGO.